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ABSTRACT: Submicron to small-micron sized particles of the hydrophobic drug, fenofibrate, 
were prepared by controlled crystallisation in order to influence its dissolution behaviour. An 
antisolvent precipitation process successfully generated particles (200-300 nm) which matched 
the size and dissolution behaviour of a commercial wet-milled formulation of the drug. Although 
the preparation of submicron sized particles was straightforward, retaining their size in 
suspension and during isolation was a challenge. Additives were employed to temporarily 
stabilise the suspension, and extend the time window for isolation of the submicron particles. 
Precipitated particles were isolated primarily by immediate freeze-drying, but drying stresses 
were found to destabilise the fragile submicron system. The growth pathway of particles in 
suspension, and during oven and freeze-drying were compared. Although the growth pathways 
appeared considerably different from a visual morphological perspective, an investigation of the 
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electron diffraction patterns, and the inner-particle surfaces showed that the growth pathways 
were the same; molecular addition by Ostwald ripening. The observed differences in the time-
resolved particle morphologies were found to be a result of the freeze-drying process.  
1.   INTRODUCTION 
It is estimated that 40% of new chemical entities fail to reach commercialization because of their 
poor water-solubility, dissolution rates and oral bioavailability, which combine to cause 
administration difficulties 
1
. An orally administered drug must dissolve in the gastrointestinal 
(GI) tract before permeating through lipophilic physiological barriers and entering the blood 
stream. While a degree of lipophilicity aids transportation of the drug across these barriers, it can 
hinder its dissolution ability in the aqueous environment of the GI tract. Poor drug dissolution 
can lead to incomplete and irregular absorption. Consequently, the dose must be increased or 
administered with food to enhance the dissolution and achieve the necessary therapeutic 
requirements.  One feasible strategy to alleviate food effects and improve the dissolution 
properties of water-insoluble (BCS Class II and IV) drugs is to decrease their particle size 
2
. 
According to the Noyes Whitney equation, reducing the particle size and so increasing the 
specific surface area, leads to an increase in the dissolution rate 
3
. Size reduction of poorly water-
soluble drugs to the submicron scale offers the opportunity to address many of the deficiencies 
associated with hydrophobic drug formulations and could potentially save many prospective 
drug candidates from abandonment after discovery.  
Examples of commercially available oral drug formulations which utilize submicron particles 
to reach their delivery goals include; RAPAMUNE (sirolimus, milled), EMEND (aprepitant, 
milled), TriCor (fenofibrate, milled), MEGACE ES (magestrol acetate, milled), and Triglide 
(fenofibrate, jet-stream homogenized) 
4
. Currently, diminution techniques such as milling are the 
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most popular industrial approaches to generate submicron particles. However, these techniques 
are grossly energy intensive and inefficient, with only 1-2% of the applied energy being used for 
size reduction 
5
. Diminution processes also limit control of particle size, morphology and surface 
properties, can take long times to achieve the required size, can introduce impurities from 
abrasion of the milling media, and can lead to thermal/mechanical degradation of temperature-
sensitive materials 
6-8
.  
Controlled crystallization/precipitation offers a potentially more efficient approach to generate 
fine particles, with better control over the particle properties. Antisolvent precipitation could 
provide a cheap and technologically easy route to the industrial production of submicron 
particles by using a simple process at ambient conditions, and low cost equipment with good 
scale-up prospects. While industrial applications of the antisolvent process are so far limited, this 
approach to fine particle production has been used in many academic studies. Particle sizes of the 
hydrophobic drugs beclomethason dipropionate 
6
, carbamazepine 
9
 and deflazocort 
10
 were 
manipulated by varying certain parameters of the antisolvent precipitation process when water 
was used as the antisolvent. However, in the preparation of submicron to small micron sized 
particles, additives are usually required to stabilize the precipitated particles against growth and 
aggregation 
11
. Common pharmaceutical stabilizers include polymers: cellulose derivatives, 
povidones, phospholipids, poloxamers (pluronics); and surfactants: Tween-80 and sodium 
dodecyl sulphate (SDS).  Khan et al. (2013) used additive-controlled antisolvent precipitation to 
stabilize suspended particles of artemisinin (400 nm), ibuprofen (92 nm) and glyburide (298 nm) 
for 30 days using combinations of Pluronic F127, PVP-K30, HPMC and sodium deoxycholate 
12
.  
Hu et al. used a similar approach to temporarily stabilize a suspension of fenofibrate (300-400 
nm) for 6 minutes using HPMC, SDS and lactose 
11
.  
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Particles prepared by antisolvent precipitation can grow by the traditional mechanism of 
molecular addition (ie. Ostwald ripening) or by the more recently proposed oriented-attachment 
and assembly mechanism 
13, 14
. Unlike traditional molecule-by-molecule crystal growth, growth 
by oriented attachment occurs through self-assembly of primary submicron particles into ordered 
superstructures or ‘mesocrystals’, which can subsequently fuse to form a single crystal 13, 14.  
In this work, submicron sized particles of a model drug, fenofibrate, were prepared using a 
simple antisolvent precipitation process. The submicron particles were stabilized in suspension 
using a series of additives, and a discussion is herein provided as to why the additives have 
superior or inferior stabilization capabilities based on the molecular chemistry of both the drug 
and the additive molecules. The novelty of the work lies not only in the improved stabilization 
achieved here compared to a previous report, under comparable conditions 
11
, but also in the 
investigation into the effect of freeze-drying, and the effect of stabilizer presence during freeze-
drying, on the final size, morphology and observed growth pathway, which has not been reported 
elsewhere. Here, we highlight the influence of the isolation process on the resulting size and 
morphology, and the corresponding influence of both the size and morphology on the dissolution 
rate. These isolation-related effects were found to be particularly critical when trying to obtain 
submicron particles in the solid form.   
Fenofibrate (FF) is a cholesterol-controlling, BCS class II hydrophobic drug (log P 5.3) with 
extremely limited solubility in water (< 0.5 µg/mL at 25˚C 15). The drug in its conventional form 
has restricted oral bioavailability and exhibits positive food effects (absorption is 35% higher in 
fed state). Particle size reduction to the submicron range eliminates food requirements 
16
. The 
molecular structure of FF is shown in Figure 1.  
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Figure 1. Molecular structure of fenofibrate. 
 
2.   EXPERIMENTAL SECTION 
2.1 Materials. Fenofibrate (FF) (99.7% purity) was generously gifted from Abbvie 
Laboratories. Ethanol (99.8% purity) was purchased from Merck Millipore. Stabilizers; 
polyvinyl alcohols (PVA, MW: 9-10 kDa, 13-23 kDa, 85-124 kDa, 146-186 kDa), 
hydroxylpropyl methyl cellulose (HPMC, ~ 26 kDa), sodium dodecyl sulphate (SDS), d-lactose 
monohydrate (lactose), polyvinyl pyrrolidone K30 (PVP-K30, 40 kDa), Pluronic F127 (~12.5 
kDa) and Kolliphor 188 (7-9 kDa) were purchased from Sigma Aldrich and polyethylene glycol 
(PEG, 3.4 kDa) was purchased from Polysciences Inc.. Hydrochloric acid and Tween-80 were 
purchased from Sigma Aldrich for use in dissolution testing. TriCor tablets (commercial 
submicron formulation) were purchased from Abbott. 
2.2. Antisolvent process parameters. The solubility of FF in ethanol at 25°C was 
gravimetrically determined. The antisolvent process conditions were optimized by monitoring 
the effects of drug concentration (10, 30, 50 mg/mL), antisolvent to solvent (AS/S) volume ratio 
(5, 10, 20, 40 [constant FF mass in AS/S mixture: 1.82 mg/mL]), agitation rate (200, 500, 800 
rpm) and aging time (up to 31 min) on the resulting size and morphology after precipitation. The 
AS/S experimental set was conducted at 30°C. All other experiments were conducted at 25°C.  
2.3. Effect of additives on the antisolvent process. An organic solution of FF in ethanol (1 
mL, 50 mg/mL) was quickly introduced by eppendorf pipette to water (10 mL) with or without 
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additives at the compositions outlined in Table 1. Solutions/suspensions were maintained at a 
constant temperature of 25°C under rapid agitation (800 rpm) throughout the precipitation 
process. On contact with the antisolvent, the FF immediately precipitated giving a fine milky 
suspension. In cases where the particles were dried, the FF suspension was flash frozen in liquid 
nitrogen and freeze-dried under vacuum (< 27 Pa) for 48 h using a Dura-Dry Microprocessor 
Control freeze-dryer. Alternatively, a drop of suspension was quickly oven-dried at 55°C. The 
reference sample refers to an un-stabilized system in which no additives were present in the 
antisolvent during precipitation. 
Table 1. Additive systems used during antisolvent precipitation 
Expt. Additive system Additive 
conc. in AS 
(%w/v) 
Additive 
screening 
PVP-K30 
0.1 % 
 
Pluronic F127 
PVA  
HPMC 
SDS 
Kolliphor 188 
PEG 
Combinations  
of above additives 
0.1 % each 
PVA: 
molecular 
weight 
PVA (9-10 kDa) 
0.1 % 
 
PVA (13-23 kDa) 
PVA (85-124 kDa) 
PVA (146-186 kDa) 
PVA: 
Conc. 
PVA (9-10 kDa) 
0.01 % 
0.05 % 
0.1 % 
0.2 % 
0.35 % 
0.5 % 
0.75 % 
2.0 % 
Prep A 
No additives 
(reference) 
N/A 
Prep B HPMC 0.05 % 
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SDS 0.05 % 
Lactose 1 % 
Prep C PVA (9-10 kDa) 0.2 % 
 
2.4. Particle size analysis. Particle size measurements were performed by laser diffraction on 
a Malvern Mastersizer 2000, with water as the dispersion medium. Precipitated suspensions were 
diluted by a factor of 5 with water (0.91 mg/mL FF) prior to their introduction to the sample 
chamber. An obscuration of 7-10%, a stir rate of 2600 rpm, a one minute pre-measurement delay 
and 5% sonication power (wrt Malvern Mastersizer 2000 sonication scale) were used during all 
size measurements. Runs were conducted at room temperature and 4 measurements were 
recorded for each run. When no stabilizing additives were present during precipitation, HPMC 
and SDS were added to the water dispersant (0.038 mg/mL) to minimize variation between 4 
consecutive measurements. Size distributions for FF were calculated using a refractive index of 
1.55 and an absorption index of 0.01. Freeze-dried particles were redispersed in water at 0.91 
mg/mL before size measurements. The D[4,3] volume-weighted mean diameter was reported for 
each size distribution.  Sizing experiments were carried out at least in duplicate. 
The size of FF particles in TriCor tablets were measured using dynamic light scattering on a 
Malvern Zetasizer. Tablets were ground with a pestle and mortar for 2 minutes and the powder 
was suspended in water (1 mg/mL FF). The large insoluble excipients were removed by vacuum 
filtration through a hydrophilic 1.2 µm Millipore membrane filter (RAFT04700). The size of the 
sub-1.2 µm particles was measured and these particles were captured by further filtering the 
suspension through a 0.22 µm PVDF membrane filter. FTIR (Perkin Elmer Spectrum 100 FT-IR 
Spectrometer) confirmed that the submicron particles were FF.  
2.5. Scanning Electron Microscopy. Sizes and morphologies of particles in dried samples 
were analyzed using a Hitachi SU-70 high-resolution scanning electron microscope (SEM). 
 8 
Freeze-dried particles were placed directly on carbon tape on an aluminum stub. Oven-dried 
particles were prepared by drying the suspension directly on the carbon tape in an oven at 55°C 
(drying took approx. 12 min). For both preparation methods, samples were coated with an ~8 nm 
gold deposit using an EMITECH K55 and the particles were imaged in field-free mode at a 
voltage of 10 kV and a working distance of 10 mm. The image analysis software, ImageJ, was 
used to analyze particle sizes from SEM images. All SEM images show particles which were 
fully representative of the entire sample analyzed in each case.  
2.6. X-ray diffraction. Powder X-ray diffraction (XRD) was used to identify the polymorphic 
form and to monitor the degree of crystallinity of the ‘as received’ and precipitated samples. 
Diffraction patterns were recorded using a PANalytical Empyrean diffractometer in transmission 
mode using Ni filtered Cu Kα radiation (λ = 1.54 Å) at 40 kV and 40 mA. Powder samples were 
prepared by trapping a small amount of powder between two strips of amorphous scotch tape and 
scanning the samples in the angular range of 5° (2θ) to 35° (2θ).  
2.7. Transmission Electron Microscopy and Electron Diffraction. Surface morphology 
analysis and selected area electron diffraction (SAED) of freeze-dried PVA-precipitated FF 
particles were conducted using a transmission electron microscope (TEM, Joel JEM-2011 
equipped with GATAN Multiscan CCD camera, model 794) at an accelerating voltage of 200 
kV.  The dried samples were suspended in deionized water and placed in a sonication bath for 30 
min before applying a drop of the suspension to a holey carbon-supported TEM grid and air 
drying overnight. Diffraction patterns were obtained before TEM imaging to minimize the 
effects of beam damage on the diffraction results. 
2.8. Focused Ion Beam. A focused ion beam (FIB) system (FEI 200, 30 kV, Ga+ ions) was 
employed to cut through the precipitated FF particles. Particles were mounted on an aluminum 
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stub and gold-coated before analysis. The part of the particle to be protected from the beam was 
coated with a 1 µm layer of platinum. The cut particles were tilted through 45° and their cross-
sections were imaged. Three particles were analyzed for each sample studied.  
2.9. Dissolution studies. A 0.1M HCl solution containing 0.4% w/v Tween-80 was used as the 
dissolution medium (DM).  
2.9.1. Solubility: Prior to dissolution rate testing, the solubility of FF (‘as received’, TriCor and 
precipitated samples) in the DM was measured in order to determine sink conditions for 
dissolution testing. The solubility was determined by UV/vis spectroscopy (Cary 300 Bio, λ - 
288 nm) by increasing the FF amount in the DM until the saturation limit was reached, as seen 
by a plateau effect in the calibration curve.  
2.9.2. Dissolution rate testing: Dissolution tests were carried out in sink conditions at approx. 1/5 
of the solubility concentration. Tests were carried out at 42°C and conducted by adding a sample 
(solid or suspension) containing 25 mg FF to 900 mL of the DM. TriCor tablets were ground by 
pestle and mortar for 2 min, prior to dissolution testing. After sample addition, 4 mL aliquots 
were taken at regular intervals from the bulk solution in preheated (45˚C) plastic syringes and 
filtered through preheated (45˚C) PTFE 0.2 μm syringe filters. The dissolved FF concentration 
was measured by UV/visible spectroscopy (Cary 300 Bio, λ - 288 nm). Dissolution rates are 
expressed as the % dissolved/second over the first 30 seconds of dissolution. Dissolution tests 
were carried out at least in duplicate. It was noted that the presence of ethanol (0.055 mL/100 
mL DM) in the suspended samples had no significant impact on the dissolution rate or overall 
solubility.  
 
3.   RESULTS 
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3.1. Effect of antisolvent process parameters. The solubility of FF in ethanol at 25°C was 
found to be 63 mg/mL. The highest drug concentration tested during antisolvent precipitation 
(Prep A, 50 mg/mL) produced the smallest particles (200-300 nm, aging time 0.5 min), with a 
monomodal distribution, Figure 2. Lower drug concentrations produced bimodal distributions 
consisting of both submicron and micron range particles. The antisolvent to solvent (AS/S) 
volume ratio and the agitation rate had no obvious impact on the particle size over the ranges 
tested (Figure S1).  
 
 
Figure 2. Particle size distributions of FF precipitated from varying drug concentrations at an 
aging time of 0.5 min.  
Based on the size results obtained for the reference sample (no additives, Prep A), a drug 
concentration of 50 mg/mL, an AS/S ratio of 10:1 and an agitation rate of 800 rpm were chosen 
as the standard process conditions for additive-based precipitation studies.  
3.2. Effect of additives on the growth of precipitated particles in suspension 
Preparation of submicron particles by precipitation was found to be relatively easy, but 
stabilization of these particles was more difficult. All additive systems tested provided enhanced 
stabilization of suspended submicron particles compared to the reference sample, Figure 3. 
Results pinpointed PVA as the most effective stabilizer both by preserving the particles in the 
submicron size range for the longest time (~11 min) and by providing long term stabilization for 
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the 4-5 µm particles which developed by 21 min. Kolliphor 188 also stabilized particles in the 
submicron range for at least 11 min, but its longer term stabilization ability (beyond 21 min) was 
poor, with the particles quickly reaching 20 µm (data not shown). No further improvements in 
stabilization were observed when PVA was used in mixtures with other additives, Figure 3. 
Additional analysis indicated that PVA with a molecular weight of 9-10 kDa at a concentration 
of 0.2% w/v provided the optimum stabilization of FF (Figure S2). Increasing the PVA 
concentration above 0.2% did not improve the stabilization.  
Figure 3. Size of precipitated FF as a function of additive system and aging time.  
Figure 4 shows the progression of the particle size distributions over time for three antisolvent 
systems: the reference sample (no additives, Prep A),  HPMC/SDS/lactose (as a comparison to 
results by Hu et al. 
11
, Prep B) and PVA (Prep C). The time-resolved graphs in Figure 4 show the 
time at which the particles grow out of the submicron range.   
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Figure 4. Evolution of the particle size distributions over time for FF precipitated with (a) no 
additives (reference), (b) HPMC/SDS/lactose and (c) PVA 
The mean particle size was determined for each distribution. Figure 5 shows that submicron 
particles were preserved for 2 min for the reference sample, 6 min when precipitated in 
HPMC/SDS/lactose and 11 min when precipitated in PVA. In each system, the initial period of 
slow growth was followed by a period of accelerated growth, before the size plateaued and no 
further growth occurred, Figure 5.  
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Figure 5. Particle size evolution of FF precipitated with no additives (reference), 
HPMC/SDS/lactose and PVA 
Time-resolved SEM images of oven-dried drops of PVA-precipitated suspensions showed 
particles with a similar growth rate to the suspended particles, with the size gradually increasing 
from 0.38 µm to 4.7 µm, at a time scale comparable to that of the suspended particles, Figure 6. 
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Therefore, particles dried in this way were taken as being representative of the particles in 
suspension.  
 
Figure 6. SEM images showing the size evolution of oven-dried PVA-precipitated FF particles 
at 40 second intervals from (a) aging time ≈ 12 minutes to (b) to (c). Image (c) represents the 
final observed particle size and morphology.  
 
The dissolution rate of the suspended submicron PVA-precipitated particles (200-300 nm, 
2.55% dissolved/s) was equivalent to that of the commercial formulation (260 nm, 2.45% 
dissolved/s), Figure 7. The dissolution rate of the larger 4-5 µm particles was lower at 0.55% 
dissolved/s. Additives were found to have no influence on the solubility of FF in the dissolution 
media (130 mg/900 ml).  
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Figure 7. Dissolution profiles of commercial and ‘as received’ powder samples and PVA-
precipitated suspensions of FF at aging times 0.5 and 31 min.  
 
3.3. Effect of freeze-drying on the size and growth pathway  
Re-dispersion of freeze-dried particles precipitated from PVA (Prep C) indicated that particles 
with a pre-dried size of 4-5 µm could maintain their size during drying while submicron particles 
could not. Particles with a pre-dried size of 200-300 nm grew/agglomerated to 16 µm during 
drying, as determined by laser diffraction (Figure S3).  
SEM images of particles precipitated from all three antisolvent systems (Prep A-C), aged for 
<2 min, showed limited evidence of submicron particles after freeze-drying. Precipitation from 
the reference system produced chunky, faceted FF crystals which grew to a mean size of 4.1 µm 
within 15 minutes (Figure 8a). Precipitation in HPMC/SDS/lactose showed a non-uniform 
crystal habit over time. Although some sub-micron spheres (0.9 µm) were observed when aged 
for 2 min, they gradually evolved into flat elongated 4 µm plates with fused tips to form 
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aggregated structures of approx. 10 µm in length (Figure 8b). Over time, PVA-precipitated FF 
particles developed from smooth-surfaced but rounded, immature and irregular particles at 0.5 
minutes, to roughly-surfaced particles at 11 and 21 minutes, to smooth-surfaced parallelepiped-
shaped particles with defined edges at 31 minutes. (Figure 8c, Figure 9).  
 
 
Figure 8. Time-resolved SEM images of freeze-dried FF precipitated with (a) no additives 
(reference) (b) HPMC/SDS/lactose, and (c) PVA.  
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Figure 9. Higher magnification SEM images of PVA-precipitated FF at aging times of (a) 11 
min, (b) 21 min and (c) 31 min (freeze-dried) 
 
Dissolution testing of freeze-dried samples (Figure 10) showed that dissolution of the reference 
sample aged for 2 min was higher than that of a sample which was aged for 30 min. The 
dissolution rate of HPMC/SDS/lactose-precipitated particles, aged for 2 and 30 min were similar. 
The dissolution rate of PVA-precipitated particles aged for < 2 min was lower than that of 
particles which were aged for 31 min, Figure 10. The 31 minute PVA-precipitated sample 
showed the best dissolution rate of all the dried samples (0.45% /s).   
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Figure 10. Dissolution profiles of freeze-dried FF samples precipitated with no additives 
(reference), HPMC/SDS/lactose, and PVA, along with the dissolution profiles of the commercial 
and ‘as received’ samples. 
XRD analysis in combination with data from the Cambridge Structural Database showed that 
all freeze-dried samples precipitated from PVA (Prep C) crystallized in the polymorphic form I 
(centro-symmetric triclinic space group P-1)
17
. The diffraction patterns are shown in Figure 11.  
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Figure 11. X-ray diffraction patterns of (A) theoretical form I (triclinic), (B) blank background, 
and (C) ‘as received’ FF; and of freeze-dried, PVA-precipitated FF at aging times of (D) 0.5 min, 
(E) 11 min, (F) 21 min, and (G) 31 min. 
Selected area electron diffraction (SAED) patterns of the 11, 21 and 31 minute PVA-
precipitated samples (from Figure 9) are shown in Figure 12.  Diffraction patterns obtained from 
the aggregates in the 11 min sample appeared as rings depicting their polycrystalline nature 
(Figure 12A). Many of the spherical submicron clusters at the tips of the aggregates produced a 
blurred halo, with no visible discrete diffraction spots, thus showing their amorphous nature 
Figure 12B. In contrast, the diffraction patterns obtained from particles in both the 21 min and 31 
min samples appeared as discrete, ordered diffraction spots, portraying the particles as single 
crystals (Figure 12C-D). 
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Figure 12. TEM micrographs and SAED patterns of freeze-dried, PVA-precipitated FF particles 
at aging times of (A) 11 min, (B) 11 min (submicron clusters), (C) 21 min, and (D) 31 min 
The inner structures of the roughly-surfaced 21 min particles were examined by cutting along 
the length of the crystals with a focused ion beam. Despite the rough surface on the particle’s 
exterior, the interior was predominantly solid, compact and void of cavities, apart from a 
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porous/spongy region at each tip, Figure 13. Similar analysis of the 31 min smooth-surfaced 
particles showed a solid interior with no inner porosity (data not shown).  
 
 
Figure 13. Image of a 21 min PVA-precipitated particle (a) before, and (b) after cutting by FIB. 
The particle in (b) is tilted by 45° and the red line designates the external surface of the original 
crystal inside a layer of re-deposited material.  
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4.   DISCUSSION 
Precipitation is a solid-forming process which is triggered by conditions of high supersaturation. 
During precipitation, rapid nucleation is followed by particle growth. The supersaturation level 
controls the nucleation rate which in turn controls the particle size. High supersaturation which is 
induced by high drug concentration and high AS/S ratio encourages nucleation to dominate over 
growth, resulting in the formation of smaller particles, as reported previously for many 
compounds 
6
 
9, 18
. The inverse trend between concentration/drug mass and size validates that it is 
not the growth rate, but the nucleation rate, and ultimately the number of particles than governs 
the particle size. While these trends were also observed here, it was found that at comparable 
supersaturation levels, variations in the concentration had a bigger influence on the particle size 
than variations in the AS/S volume ratio.  This result can be explained by differences in the local 
supersaturation at the point of injection of the drug solution. The drug mass varies with 
variations in the concentration (at a fixed AS/S ratio). Higher concentration, and thus higher drug 
mass, induces a steep local supersaturation gradient at the drug solution/antisolvent interface 
before uniformity is achieved by mixing. The effects of local supersaturation gradients are 
smaller for changes in the AS/S volume ratio since the added drug mass is constant.  
Using optimum antisolvent process parameters, submicron sized particles were successfully 
produced by antisolvent precipitation. However, due to their high surface energy, additives were 
required to stabilize the submicron particles in suspension and during isolation. The growth rate 
of precipitated particles depended on the additive system used.  Of the systems tested, PVA 
provided the most successful stabilization for FF particles in suspension. PVA is an FDA-
approved GRAS additive (generally recognized as safe), which has been reported to stabilize 
particles by coating them with a thick and stable protective layer 
19
. This polymer has an 
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abundance of hydrogen bond donors and no acceptors, while FF has four hydrogen bond 
acceptors and no donors. This combination gives PVA high potential to hydrogen bond with FF 
surfaces, thus allowing it superiority over other additives in stabilizing the drug. While many of 
the other tested additives have functional groups capable of hydrogen bonding (eg. the pluronics, 
PEG, HPMC, PVP-K30), the presence of hydrogen bond accepting groups in these molecules 
limits their ability to interact with FF. Molecules with both accepting and donating capabilities 
can form intramolecular and interchain hydrogen bonds, thus decreasing their drug-polymer 
interaction potential. The initial stabilization induced by Kolliphor 188 was attributed to its lower 
molecular weight compared to the other polymers tested, which lessens its steric effects on 
interacting with the FF molecule. However, the presence of both hydrogen bond accepting and 
donating groups in this molecule dampens its longer term stabilization abilities.  The stabilization 
efficiency of PVA for the precipitated particles was further improved by selecting the 
concentration and molecular weight which induced the slowest growth rate. It is likely that these 
optimum conditions indicate the point at which the surface coverage and coating thickness of the 
PVA were respectively maximized. PVA enhanced the stability of submicron FF particles 
compared to that reported previously for this compound under comparable preparation 
conditions 
11
.  Unlike other reports which utilize antisolvent precipitation to control the size of 
FF particles
20-22
, this system was carried out without the addition of ultrasonication, making scale 
up prospects more feasible. The size and dissolution rate of the suspended PVA-stabilized 
submicron particles matched those of the milled particles in the commercial formulation, TriCor. 
To our knowledge this comparison has not been shown in previous reports on precipitated FF 
11, 
20, 23, 24
.  
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Results from SEM (Figure 8) and dissolution testing (Figure 10) indicated that the precipitated 
submicron particles were not preserved as individual entities during freeze-drying. For all three 
antisolvent systems (preparations A-C), the dissolution rates of dried particles (Figure 10) were 
poorer than those of their suspended equivalents. Dissolution testing of the freeze-dried reference 
samples (Prep A) showed that an increase in particle size [as observed by SEM, (Figure 8)] 
resulted in a decrease in dissolution rate (Figure 10). FF precipitated by Prep B showed similar 
dissolution rates for 0.9 µm spheres at 2 minutes, and 4 µm plates at 30 minutes. The similarity 
in dissolution rates is attributed to the change in the particle shape from spheres to plates, thus 
maintaining a relatively constant surface area/volume ratio, Figure 10 and 8b.  The poorer 
dissolution rate of PVA-precipitated FF (Prep C) at 0.5 minutes compared to 31 minutes can only 
be explained by aggregation and fusion of insufficiently stabilized submicron particles (at 0.5 
min) during the destabilizing drying process, Figure 14.] 
 
Figure 14. Schematic description of the hypothesized growth mechanism of particles in 
suspension, highlighting the drying-induced morphologies of freeze-dried particles  
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Visually different growth patterns were detected for PVA-precipitated particles isolated by 
oven-drying (Figure 6, representative of suspended particles) and those isolated by freeze-drying, 
Figure 8c, 9. The suspended and oven-dried particles gradually evolved from submicron to small 
micron size in a manner corresponding to Ostwald ripening. Figure 4 shows the growth of the 
larger particles in suspension at the expense of the submicron particles. Depletion of the 
submicron particles prevented further growth in suspension, resulting in a plateaued stable 
particle size of 4-5 µm. Analysis of freeze-dried particles (Figure 8c) presented a visually 
different morphological development of particles over time, which appeared inconsistent with 
the classical Ostwald ripening mechanism. The change in morphologies of the isolated particles 
from irregular immature crystals at 0.5 min, to aggregated submicron particles at 11 min, to 
roughly-surfaced and then smooth-surfaced parallelepiped crystals at 21 and 31 min is attributed 
to the freeze-drying process (Figure 14). While submicron particles existed in suspension at 0.5 
min (Figure 5), they were not observed in the corresponding freeze-dried sample (Figure 8c). It 
is proposed that this short aging time was insufficient for the PVA to bond to, and stabilize the 
suspended submicron particles. The subsequent drying step caused aggregation, followed by 
fusion of the un-stabilized 0.5 min particles. At 11 minutes, freeze-drying again forced 
aggregation of the submicron particles, but the PVA-coating prevented the fusion step from 
occurring (Figure 14). During the period of accelerated growth between 11 and 21 minutes, 
submicron and small micron particles coexisted in suspension (Figure 4) but drying forced the 
submicron particles to surface-attach to the larger particles. By 31 minutes, no submicron 
particles remained in suspension (Figure 4c). This explains why these particles maintained their 
smooth surface during drying. Based on time-resolved particle sizing and SEM imaging, it is 
hypothesized that PVA-precipitated particles grow by Ostwald ripening in suspension followed 
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by forced aggregation, attachment and/or fusion during the freeze-drying step. It must be 
clarified that the morphological development of the freeze-dried particles with time is not the 
result of a continuous growth process, but a knock-on effect from isolation of the growing 
particles at various time points (Figure 14).  
However, SEM analysis alone was insufficient in distinguishing if the visible submicron 
particles in the 11 and 21 min samples in Figure 8c were truly a surface event or if they extended 
throughout the entire structure in an assembled fashion (ie. as a mesocrystal). FIB analysis 
verified that the interior of the 21 minute particles was predominantly solid and free of the 
cavities which would be associated with particle assembly into mesocrystals. The porous region 
at the particle tips (consistent for all 21 min particles analyzed) was caused by the visible coating 
of submicron particles these areas. This porous region was not observed for the smooth-surfaced 
31 min particles.  
SAED analysis defined the 11 min particles as polycrystals which formed when the submicron 
particles aggregated during drying. Results showed that particles which were aged for 21 min 
were single crystals, despite their rough surface. A likely explanation as to how a polycrystalline 
aggregate would develop into a highly-crystalline single crystal (confirmed by XRD, Figure 11) 
is through the traditional Ostwald ripening pathway, whereby the inner particle gradually grows 
at the expense of the remaining submicron particles.  
Therefore, despite the appearance of an unusual growth trend for freeze-dried PVA-
precipitated FF from time-resolved SEM analysis, results from FIB and SAED indicated that the 
growth mechanism was no different to that of the suspended particles. The visual differences 
were found to be related to the drying process. For this reason, examination of the crystal habits 
alone can be misleading in determining the growth mechanism, leading to frequent 
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misinterpretation. Results have shown that the effect of the drying process on the system is quite 
significant and must also be considered. 
 
5.   CONCLUSION 
Submicron sized FF particles (200-300 nm) were successfully precipitated with an equivalent 
size and dissolution rate to that of a milled commercial nanoformulation, without the use of 
ultrasonication. The stability of the particles in the submicron size range was short-lived and 
additives were required to slow their growth rate. PVA showed the most effective stabilization 
for FF due to the characteristic hydrogen bonding capabilities of both PVA and FF, compared to 
the other additives tested. The stabilization of the suspended submicron particles by PVA was 
only temporary and so immediate isolation was necessary. While freeze-drying proved 
successful in isolating small-micron sized particles, it was unsuccessful in preserving the pre-
dried submicron particles as individual entities during the drying process.  The isolation process, 
which can destabilize high energy submicron particle systems, has yet to be optimized to find the 
best conditions for preserving the submicron particle in the solid form.  
During the course of this work, it was demonstrated that the additives and isolation method 
used impacted on the final size and shape of the crystals. Both the size and shape were 
instrumental in influencing the dissolution rate. The growth pathway of FF was probed due to 
considerable differences in the crystal habits and observed growth patterns of suspended and 
freeze-dried particles. Despite visual differences, both processes were found to adhere to the 
traditional growth mechanism of molecular addition by Ostwald ripening. No evidence of 
orientated attachment or mesocrystal particle assemblies was found. Results indicated that single 
crystals became coated in a layer of submicron particles during the freeze-drying process. These 
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results demonstrate the importance of considering the effect of the drying process on the growth 
mechanism.  
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Following antisolvent precipitation and freeze-drying of fenofibrate, roughly-surfaced 
intermediate particles were observed. Both molecular addition and orientated attachment-based 
growth mechanisms were considered in an attempt to explain the particle roughness. Results 
showed that suspended particles grew by molecular addition and that the observed roughness in 
the dried particles was a result of the freeze-drying process.  
